Stockhouse.com: Taking it to the street
Latest Broadcasts
V.ARD
Technology-Internet
T.FR
Natural Resources
V.AIX
Natural Resources.
OMCY
Internet/Technology
V.KTN
Natural Resources, Metals and Mining
T.ND
Natural Resources
An excellent place to start your search for new investments!
add to favorites print

Biopharma company Maxygen (MAXY) scores deal, shares up 28%.

Shares of biopharmaceutical company Maxygen Inc. (NASDAQ: MAXY, Stock Forum) have had a healthy boost today – the price is up almost 28% to $4.46 in afternoon trading on news of a $130 million deal with Bayer HealthCare. Bayer has agreed to purchase Maxygen’s “hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as MAXY-VII.” Another part of the deal “includes a license to use Maxygen's MolecularBreeding(TM) technology, a novel research platform, for exploiting gene targets.” (Go to news release.)

In speaking about the deal, CEO of Maxygen Russell Howard offered, "MAXY-VII has the potential to become the world's first approved shuffled protein therapeutic, a milestone that is likely to open up many more opportunities for Maxygen's technology. Bayer is the ideal company to move the MAXY-VII program toward that goal."

A long-term view of the stock price of Maxygen shows this to be, for the most part, an unexciting investment. Shares have remained mostly range-bound for a couple of years, trading between $7.00 and $10.00. There was a brief pop to $12.00 in early 2007, but prices then drifted back to the range until spring, 2008, when they took a nosedive to sub-$4.00 levels. Current lows combined with good news from Bayer appears to be bringing buyers back.

 
print
 
Stockhouse Conflict and Disclosure Policy:

Stockgroup Media Inc., owners and operators of Stockhouse.com, has established the following rules to ensure that there is no appearance of impropriety on the part of any Stockhouse Editorial writers ("Writers"). The content of Stockhouse Editorial articles (the "Articles") are the opinion of the Writer and any reliance on the content of these articles is at your sole risk. Our Writers are not registered investment advisors. You should not make any kind of investment decision in relation to Articles or stocks discussed in them without obtaining advice from a registered investment advisor.

Facts relied upon by our Writers are generally provided by the subject companies or gathered by our Writers from other public and/or private sources. These facts may be in error and if so, the opinions of our Writers may be materially different.

Writers may own, buy, or sell shares in public companies mentioned in their Articles, but in the Article they must prominently state their ownership position. Thus, a conflict may exist. Writers are not permitted to write Articles that attempt to benefit persons connected to the Writer, such as family or friends, except where disclosure is made in the same way as if the Writer him/herself owns stock.

Writers cannot solicit, accept, or agree to receive anything of value given or paid with the intent of influencing their Articles.

Stockhouse notifies each Writer about these rules, and we rely on the integrity of our Writers to ensure that our rules are followed.

 
 
 
 
 
Today's Feature  
 
First Majestic Silver Corp
First Majestic Silver Corp. is a pure silver producing mining company focused in Mexico. The Company strives for continued growth with a proven aggressive growth strategy based on acquisition and development of advance staged silver projects. First Majestic has excelled in acquisition of long term sustainable projects and has set itself apart from others in the silver space lead by President and CEO, Keith Neumeyer, founder of First Quantum Minerals, a successful copper company; alongside ...